Cargando…
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359457/ https://www.ncbi.nlm.nih.gov/pubmed/36455565 http://dx.doi.org/10.18632/oncotarget.28265 |
_version_ | 1784764142379335680 |
---|---|
author | Rubatto, Marco Merli, Martina Avallone, Gianluca Agostini, Andrea Mastorino, Luca Caliendo, Virginia Barcellini, Amelia Vitolo, Viviana Valvo, Francesca Fierro, Maria Teresa Ribero, Simone Quaglino, Pietro |
author_facet | Rubatto, Marco Merli, Martina Avallone, Gianluca Agostini, Andrea Mastorino, Luca Caliendo, Virginia Barcellini, Amelia Vitolo, Viviana Valvo, Francesca Fierro, Maria Teresa Ribero, Simone Quaglino, Pietro |
author_sort | Rubatto, Marco |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9359457 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-93594572022-08-09 Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review Rubatto, Marco Merli, Martina Avallone, Gianluca Agostini, Andrea Mastorino, Luca Caliendo, Virginia Barcellini, Amelia Vitolo, Viviana Valvo, Francesca Fierro, Maria Teresa Ribero, Simone Quaglino, Pietro Oncotarget Addendum Impact Journals LLC 2022-08-04 /pmc/articles/PMC9359457/ /pubmed/36455565 http://dx.doi.org/10.18632/oncotarget.28265 Text en Copyright: © 2022 Rubatto et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Addendum Rubatto, Marco Merli, Martina Avallone, Gianluca Agostini, Andrea Mastorino, Luca Caliendo, Virginia Barcellini, Amelia Vitolo, Viviana Valvo, Francesca Fierro, Maria Teresa Ribero, Simone Quaglino, Pietro Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review |
title | Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review |
title_full | Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review |
title_fullStr | Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review |
title_full_unstemmed | Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review |
title_short | Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review |
title_sort | addendum: immunotherapy in xeroderma pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review |
topic | Addendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359457/ https://www.ncbi.nlm.nih.gov/pubmed/36455565 http://dx.doi.org/10.18632/oncotarget.28265 |
work_keys_str_mv | AT rubattomarco addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview AT merlimartina addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview AT avallonegianluca addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview AT agostiniandrea addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview AT mastorinoluca addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview AT caliendovirginia addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview AT barcelliniamelia addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview AT vitoloviviana addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview AT valvofrancesca addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview AT fierromariateresa addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview AT riberosimone addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview AT quaglinopietro addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview |